Andere talen Xbrane Biopharma AB

Aandelen

XBRANE

SE0007789409

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:29:41 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,2165 ^SEK	+4,09%		-40,52%	-97,83%

22/04	Transcript : Xbrane Biopharma AB - Special Call
26/02	Transcript : Xbrane Biopharma AB, 2023 Earnings Call, Feb 26, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Xbrane provides regulatory update on FDA review of its ranibizumab biosimilar candidate	21/04
Notice of annual general meeting in Xbrane Biopharma AB	02/04
Change of number of shares and votes in Xbrane	01/04
XBRANE BIOPHARMA RELEASES ANNUAL AND SUSTAINABILITY REPORT FOR 2023	27/03
Xbrane resolves on a directed issue of shares to guarantors in connection with the completed rights issue	19/03
Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index	18/03
Xbrane announces the outcome of the rights issue	14/03
Xbrane publish supplement to prospectus	08/03
Xbrane has received additional subscription undertakings corresponding to approximately SEK 18.1 million in the Company's rights issue	04/03
Xbrane Biopharma Q4 2023 - Navigating muddy waters	01/03
Trading in unit rights and BTUs in Xbrane's rights issue will commence on 29 February 2024	27/02
Xbrane publishes prospectus in connection with the company’s partially guaranteed rights issue of approximately SEK 343 million	27/02
Xbrane Biopharma releases Year-end Report 2023	26/02
Xbrane Biopharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/02
Xbrane Biopharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Announcement from Extra General Meeting in Xbrane Biopharma AB	22/02
Invitation to presentation of Xbrane Biopharma’s Year-end report 2023 on February 26, 2024	21/02
Xbrane sends shareholder letter in connection with the proposed rights issue	05/02
Notice of Extra General Meeting in Xbrane Biopharma AB	22/01
Xbrane announces a rights issue of units of approximately SEK 343 million	22/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Xbrane Biopharma AB

Aandelen

XBRANE

SE0007789409

Andere talen

Filters